Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS)-Reference-Cited by-同舟云学术

Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS)

Published:2022-12 Issue: Volume: Page:102308
ISSN:1521-6934
Container-title:Best Practice & Research Clinical Obstetrics & Gynaecology
language:en
Short-container-title:Best Practice & Research Clinical Obstetrics & Gynaecology

Author:

Grynberg M.,Cedrin-Durnerin I.,Raguideau F.,Herquelot E.,Luciani L.,Porte F.,Verpillat P.,Helwig C.,Schwarze J.E.,Paillet S.,Castello-Bridoux C.,D'Hooghe Thomas,Benchaïb M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Medicine

Reference66 articles.

1. The international glossary on infertility and fertility care, 2017;Zegers-Hochschild;Fertil Steril,2017

2. New human follitropin preparations: how glycan structural differences may affect biochemical and biological function and clinical effect;Dias;Front Endocrinol,2021

3. Comparative characterisation of a commercial human chorionic gonadotrophin extracted from human urine with a commercial recombinant human chorionic gonadotrophin;Bassett;Curr Med Res Opin,2005

4. Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?;Driebergen;Curr Med Res Opin,2003

5. Comparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin alpha);Lispi;Reprod Biomed Online,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues – Critical appraisal on “Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France”;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-09

2. A letter to editor – Critical appraisal on “Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.”;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-09

3. Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-06

4. Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study;Frontiers in Endocrinology;2024-02-12

5. Preface: Health economics and outcomes research in reproductive medicine: Methods and comparative effectiveness of treatment protocols;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-02